| THE FORMULARY SYSTEM:
3.3 SPECIAL ACCESS DRUGS POLICY All non marketed drugs that are prescribed in the hospital, including inpatient and outpatient services, shall be designated special access drugs. These drugs are not available on the market in Canada but are made available to practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, are unavailable, or offer limited options. The Special Access Program* (SAP) of the Therapeutics Products Program (formerly Health Protection Branch) authorizes a manufacturer to sell a specific quantity of a drug to a physician or pharmacy. PROCEDURES Physician:
Pharmacy:
* The Special Access Program was formerly called the Emergency Drug Release Program. |